Tel Aviv / Zurich, April 12, 2018 – SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN) (“SHL”), a leading provider and developer of advanced personal telemedicine solutions, announced that at the Annual General Meeting of the Shareholders which was held today in Tel-Aviv, Israel, the following six members of the Board were elected, by alphabetical order: Mr. Yi He (re-appointed), Prof. Amir Lerman (re-appointed), Dr. Yuan-Hsun Lo, Ms. Yirong Qian, Mr. Cailong Su (re-appointed), and Mr. Xuewen Wu (re-appointed). These directors will serve until the next annual general meeting of the shareholders of the Company. The terms of Mr. Elon Shalev, a former member of the Board of Directors and again proposed as a candidate for a new term, as well as of Ms. Shenlu Xu, who did not stand for re-election, have terminated at this AGM. Mr. Erez Alroy, Mr. Yariv Alroy, Mr. Ziv Carthy, Mr. Elad Magal and Mr. Erez Nachtomy, which were also candidates for the Board of Directors, were not elected. Also, the attending shareholders approved the other items on the AGM agenda.
For further information please contact:
Martin Meier-Pfister, IRF Communications, Phone: +41 43 244 81 40, email@example.com
About SHL Telemedicine
SHL Telemedicine is engaged in developing and marketing personal telemedicine systems and the provision of medical call center services, with a focus on cardiovascular and related diseases, to end users and to the healthcare community. SHL Telemedicine offers its services and personal telemedicine devices to subscribers utilizing telephonic and Internet communication technology. The Company operates in Israel, Germany, India and the United States in one business segment, Telemedicine services. SHL is listed on the SIX Swiss Exchange (SHLTN, ISIN: IL0010855885, Security No.: 1128957). For more information, please visit our web site at www.shl-telemedicine.com.
Some of the information contained in this press release contains forward-looking statements. Readers are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those in the forward-looking statements as a result of various factors. SHL Telemedicine undertakes no obligation to publicly update or revise any forward-looking statements.
Click Here to read Company Press Release